Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMAL>60: Liposomal Vincristine and Optimised Rituximab in Elderly B-Cell Lymphoma
NCT01478542Phase 3Completed
- Sponsor
- Saarland University
- Start
- Nov 2011
- Primary completion
- Jan 2024
- Modality
- Small Molecules, Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of vincristine sulfate liposome in aggressive B-cell lymphoma, sponsored by Saarland University. Started Nov 2011; status: completed.
02
Drugs
vincristine sulfate liposome
03
Conditions
aggressive B-cell lymphoma
Beyond the preview
Go deeper on NCT01478542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01478542.